Fresenius | FRE - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Akzo Nobel EUR 148M 598M 2026-03
Alcon AG USD 240M 24M 2026-03
AstraZeneca USD 4.81B 894M 2026-06
BASF EUR 1.1B 25M 2026-03
Bayer EUR 321M 2.67B 2026-06
Beiersdorf EUR 408.5M 43.5M 2025-06
DaVita Healthcare Partners USD 435.01M 93.78M 2026-06
Demant DKK 1.64B 173M 2025-12
E.ON EUR 3.63B 2.44B 2026-03
Essilor EUR 2.64B 196M 2026-06
Fresenius EUR 535M 42M 2026-06
Fresenius Medical Care EUR 383M 43M 2026-06
Getinge SEK 428M 1.54B 2025-03
Givaudan CHF 642M 292M 2024-12
GlaxoSmithKline GBP 2.68B 532M 2026-06
GN Store Nord DKK -281M 280M 2026-06
GRIFOLS EUR 247M 135M 2026-06
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Lonza CHF 624M 197M 2024-12
Merck EUR 869M 468M 2026-03
Novartis USD 4.27B 430M 2026-06
Philips EUR 546M 356M 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
RWE EUR 150M 677M 2026-03
Sanofi EUR 837M 1.17B 2026-06
Smith & Nephew USD 469M 70M 2025-12